US LI-RADS in surveillance for recurrent hepatocellular carcinoma after curative treatment

被引:3
作者
Huang, Hui [1 ]
Cheng, Mei-Qing [1 ]
He, Dan-Ni [1 ,2 ]
Xian, Meng-Fei [1 ]
Zeng, Dan [1 ]
Wu, Shao-Hong [1 ]
Li, Chao-Qun [1 ,3 ]
Ruan, Si-Min [1 ]
Li, Ming-De [1 ]
Lin, Man-Xia [1 ]
Lu, Ming-De [1 ,4 ]
Kuang, Ming [1 ,4 ]
Wang, Wei [1 ]
Chen, Li-Da [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Inst Diagnost & Intervent Ultrasound, Dept Med Ultrason,Ultrasom Artificial Intelligenc, 58 Zhongshan Rd 2, Guangzhou 510080, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 7, Dept Med Ultrason, Shenzhen, Peoples R China
[3] Sichuan Univ, Dept Ultrasound Med, West China Xiamen Hosp, Xiamen, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Hepatocellular carcinoma; Recurrence; Surveillance; Ultrasound; CLINICAL-PRACTICE GUIDELINES; ATTENTION NETWORK; PREDICTION METHOD; MANAGEMENT; ULTRASOUND; DIAGNOSIS; ACCURACY; CRITERIA; NODULES; UPDATE;
D O I
10.1007/s00330-023-09903-7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
ObjectivesTo investigate the performance of US LI-RADS in surveillance for recurrent hepatocellular carcinoma (RHCC) after curative treatment.Materials and methodsThis study enrolled 644 patients between January 2018 and August 2018 as a derivation cohort, and 397 patients from September 2018 to December 2018 as a validation cohort. The US surveillance after HCC curative treatment was performed. The US LI-RADS observation categories and visualization scores were analyzed. Four criteria using US LI-RADS or Alpha-fetoprotein (AFP) as the surveillance algorithm were evaluated. The sensitivity, specificity, and negative predictive value (NPV) were calculated.ResultsA total of 212 (32.9%) patients in derivation cohort and 158 (39.8%) patients in validation cohort were detected to have RHCCs. The criterion of US-2/3 or AFP & GE; 20 & mu;g/L had higher sensitivity (derivation, 96.7% vs 92.9% vs 81.1% vs 90.6%; validation, 96.2% vs 90.5% vs 80.4% vs 89.9%) and NPV (derivation, 95.7% vs 93.3% vs 88.0% vs 91.8%; validation, 94.6% vs 89.4% vs 83.6% vs 89.0%), but lower specificity (derivation, 35.9% vs 48.2% vs 67.6% vs 51.9%; validation, 43.5% vs 52.7% vs 66.1% vs 54.0%) than criterion of US-2/3, US-3, and US-3 or AFP & GE; 20 & mu;g/L. Analysis of the visualization score subgroups confirmed that the sensitivity (89.2-97.6% vs 81.0-83.3%) and NPV(88.4-98.0% vs 80.0-83.3%) of score A and score B groups were higher than score C group in criterion of US-2/3 in both two cohorts.ConclusionsIn the surveillance for RHCC, US LI-RADS with AFP had a high sensitivity and NPV when US-2/3 or AFP & GE; 20 & mu;g/L was considered a criterion.
引用
收藏
页码:9357 / 9367
页数:11
相关论文
共 50 条
[21]   CEUS LI-RADS for diagnosis of hepatocellular carcinoma in individuals without LI-RADS-defined hepatocellular carcinoma risk factors [J].
Huang, Zhe ;
Zhou, Ping Ping ;
Li, Shan Shan ;
Li, Kaiyan .
CANCER IMAGING, 2023, 23 (01)
[22]   Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial review [J].
Voizard, Nicolas ;
Cerny, Milena ;
Assad, Anis ;
Billiard, Jean-Sebastien ;
Olivie, Damien ;
Perreault, Pierre ;
Kielar, Ania ;
Do, Richard K. G. ;
Yokoo, Takeshi ;
Sirlin, Claude B. ;
Tang, An .
INSIGHTS INTO IMAGING, 2019, 10 (01)
[23]   Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial review [J].
Nicolas Voizard ;
Milena Cerny ;
Anis Assad ;
Jean-Sébastien Billiard ;
Damien Olivié ;
Pierre Perreault ;
Ania Kielar ;
Richard K. G. Do ;
Takeshi Yokoo ;
Claude B. Sirlin ;
An Tang .
Insights into Imaging, 10
[24]   LI-RADS Ultrasound Surveillance Version 2024: Comparison With Version 2017 for Hepatocellular Carcinoma Detection and Risk Factors for Visualization Score C [J].
Heo, Subin ;
Kim, So Yeon ;
Lee, So Jung ;
Lee, Seung Soo ;
Byun, Jae Ho ;
Won, Hyung Jin ;
Shin, Yong Moon ;
Choi, Sang Hyun ;
Sirlin, Claude B. .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2025, 224 (04)
[25]   LI-RADS for CT diagnosis of hepatocellular carcinoma: performance of major and ancillary features [J].
Alhasan, Ayman ;
Cerny, Milena ;
Olivie, Damien ;
Billiard, Jean-Sebastien ;
Bergeron, Catherine ;
Brown, Kip ;
Bodson-Clermont, Paule ;
Castel, Helene ;
Turcotte, Simon ;
Perreault, Pierre ;
Tang, An .
ABDOMINAL RADIOLOGY, 2019, 44 (02) :517-528
[26]   Hepatocellular Carcinoma in Evolution: Correlation with CEUS LI-RADS [J].
Nguyen, Stephanie A. ;
Merrill, Christina D. ;
Burrowes, David P. ;
Medellin, G. Alexandra ;
Wilson, Stephanie R. .
RADIOGRAPHICS, 2022, 42 (04) :1028-1042
[27]   Feeding artery: a valuable feature for differentiation of regenerative nodule, dysplastic nodules and small hepatocellular carcinoma in CEUS LI-RADS [J].
Wu, Jiapeng ;
Zhao, Qinxian ;
Wang, Yuling ;
Xiao, Fan ;
Cai, Wenjia ;
Liu, Sisi ;
Du, Zhicheng ;
Yu, Xiaoling ;
Liu, Fangyi ;
Yu, Jie ;
Liang, Ping .
EUROPEAN RADIOLOGY, 2024, 34 (02) :745-754
[28]   Updates on LI-RADS Treatment Response Criteria for Hepatocellular Carcinoma: Focusing on MRI [J].
Patel, Richa ;
Aslam, Anum ;
Parikh, Neehar D. ;
Mervak, Benjamin ;
Mubarak, Eman ;
Higgins, Lily ;
Lala, Kayli ;
Conner, Jack F. ;
Khaykin, Valerie ;
Bashir, Mustafa ;
Do, Richard Kinh Gian ;
Burke, Lauren M. B. ;
Smith, Elainea N. ;
Kim, Charles Y. ;
Shampain, Kimberly L. ;
Owen, Dawn ;
Mendiratta-Lala, Mishal .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2023, 57 (06) :1641-1654
[29]   Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm [J].
Ania Kielar ;
Kathryn J. Fowler ;
Sara Lewis ;
Vahid Yaghmai ;
Frank H. Miller ;
Hooman Yarmohammadi ;
Charles Kim ;
Victoria Chernyak ;
Takeshi Yokoo ;
Jeffrey Meyer ;
Isabel Newton ;
Richard K. Do .
Abdominal Radiology, 2018, 43 :218-230
[30]   Clinicoradiographic predictors of progression of an intermediate hepatic lesion (LI-RADS 3) to hepatocellular carcinoma (LI-RADS 5) [J].
Hannan, Lindsay M. ;
Ojeda, Patricia I. ;
Mieloszyk, Rebecca J. ;
Harris, William P. ;
Park, James O. ;
Bhargava, Puneet .
HEPATOMA RESEARCH, 2021, 7 :7-78